Wilms' tumor: Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology
β Scribed by Robert L. Tobin; James Fontanesi; Larry E. Kun; Diane L. Fairclough; H.Omar Hustu; William J. Pao; Edwin C. Douglass; Judith Wilimas; A.P. Mahesh Kumar; Jesse J. Jenkins
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 715 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND After randomized trials in the 1980s, doxorubicin (DOX) was added to dactinomycin plus vincristine as standard chemotherapy for patients who had Stage III Wilms tumor (WT) of favorable histology (FH). Doubleβagent chemotherapy was retained for patients with Stage II disea
The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran